University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Malcolm John, M.D.

Director of the HIV/AIDS Program

Dr. Malcolm John, an expert in infectious diseases, is director of the UCSF HIV/AIDS Program at UCSF Medical Center, one of the most comprehensive HIV and AIDS treatment programs in the country. In addition to his work at UCSF, John is an HIV consultant at the Larkin Street Youth Center in San Francisco.

John's research addresses molecular and immunologic components of diseases associated with the human papillomavirus (HPV) in HIV-infected patients, particularly among African Americans. He also studies differences in HIV care, treatment and outcomes among African Americans.

John earned a medical degree at Harvard University and a graduate degree in public health at the University of California at Berkeley. He completed an infectious disease fellowship at UCSF, where he was a postdoctoral fellow in the Center for AIDS Prevention Studies. He has received numerous awards, including the Robert Wood Johnson Harold Amos Faculty Development Award. He is an assistant clinical professor in the department of medicine.

Clinics

HIV/AIDS Program
350 Parnassus Avenue, Suite 908
San Francisco, CA 94143
Phone: (415) 353-2119
Fax: (415) 353-2406

Hours: Monday to Thursday
8:30 a.m. – noon, 1 – 5 p.m.

Conditions & Treatments

More about Malcolm John

Additional Languages

French
Spanish

Education

Harvard Medical School 1994

Residencies

Massachusetts General Hospital, Internal Medicine 1995

Fellowships

Massachusetts General Hospital, Internal Medicine 1997
UCSF, Infectious Diseases 2000

Selected Research and Publications

  1. Saberi P, Yuan P, John M, Sheon N, Johnson MO. A pilot study to engage and counsel HIV-positive African American youth via telehealth technology. AIDS Patient Care STDS. 2013 Sep; 27(9):529-32.
  2. Clark T, Marquez C, Hare CB, John MD, Klausner JD. Methamphetamine use, transmission risk behavior and internet use among HIV-infected patients in medical care, San Francisco, 2008. AIDS Behav. 2012 Feb; 16(2):396-403.
  3. Lao CK, Gruta C, John MD, Cocohoba J. A comparison of tenofovir-associated renal function changes in HIV-infected African Americans vs Caucasians. J Natl Med Assoc. 2011 Jun; 103(6):518-22.
  4. Marquez C, Mitchell SJ, Hare CB, John M, Klausner JD. Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006. AIDS Care. 2009 May; 21(5):575-82.
  5. Robinson CA, Cocohoba J, MacDougall C, John MD, Guglielmo BJ. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. J Am Pharm Assoc (2003). 2007 Sep-Oct; 47(5):613-5.
  6. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996 Sep; 14(9):2527-39.
  7. John M, Pajak T, Flam M, Hoffman J, Markoe A, Wolkov H, Paris K. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am. 1996 Jul-Aug; 2(4):205-11.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.